Pharmacoeconomic advantages of using intrauterine levonorgestrel containing Mirena system in conjunction with the transdermal estrogen containing drugs for the treatment of menopausal syndrome and contraception during the menopausal transition
The current article provides the pharmacoeconomical comparison of cost-effectiveness between combined preparations for treatment of climacteric syndrome and IUD Mirena combined with trans-dermal estrogen formulations.
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Kniha |
| Vydáno: |
IP Berlin A.V.,
2016-12-01T00:00:00Z.
|
| Témata: | |
| On-line přístup: | Connect to this object online. |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Jednotka 1 | Dostupné |